TickerFacts.

Warby Parker Inc. (WRBY): Shareholders' Equity

Annual figures by period end, from SEC filings.

$367.73M
As of 2025-12-31
$391.99M
As of 2026-06-30
+8.7%
3-year compound annual growth
2019-12-31: -$189.45M2020-12-31: -$198.10M2021-12-31: $286.00M2022-12-31: $286.65M2023-12-31: $301.79M2024-12-31: $340.07M2025-12-31: $367.73M$367.73M
2019-12-31 Shareholders' Equity (USD) 2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-31$367.73M+8.1%2026-02-26, Balance as of period end
2024-12-31$340.07M+12.7%2026-02-26, Balance as of period end
2023-12-31$301.79M+5.3%2026-02-26, Balance as of period end
2022-12-31$286.65M+0.2%2025-02-27, Balance as of period end
2021-12-31$286.00Mn/m2024-02-29, Balance as of period end
2020-12-31-$198.10Mn/m2023-02-28, Balance as of period end
2019-12-31-$189.45Mn/a2022-03-18, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Ophthalmic Goods), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
Warby Parker Inc. (WRBY)2025-12-31$367.73M+8.1%
National Vision Holdings, Inc. (EYE)2026-01-03$869.53M+6.5%
Staar Surgical Co (STAA)2026-01-02$344.18M-13.4%
Cooper Companies, Inc. (COO)2025-10-31$8.24B+1.9%
Bausch & Lomb Corp (BLCO)2025-12-31$6.52B-0.4%
RxSight, Inc. (RXST)2025-12-31$275.68M-2.0%
Innovative Eyewear Inc (LUCY)2025-12-31$9.07M-0.3%

Compare WRBY, EYE, STAA, COO side by side · Screen every company in Ophthalmic Goods ↗